[Taylor&Francis] Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care 每 an overview

librarian666 Post time Yesterday 21:21 | Show all posts |Read mode
This post will be closed automatically in 2026-07-02 21:21
Reward30points

journalㄩExpert Opinion on Drug Metabolism & Toxicology

AuthorsㄩGianluca D*Onofrio; Antonella Riva; Elisabetta Amadori; Simona Lattanzi; Klaus Rose; Alberto Verrotti; Pasquale Striano

Published dateㄩ2022-9-2

DOIㄩ10.1080/17425255.2022.2117606

PDF linkㄩhttps://www.tandfonline.com/doi/pdf/10.1080/17425255.2022.2117606

Article linkㄩhttps://doi.org/10.1080/17425255.2022.2117606

Article SourceㄩInforma UK Limited


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
subhajitbhatt Post time Yesterday 21:21 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list